MK-1045 — clinical trials using this drug

Public-registry trials using MK-1045 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)	Merck Sharp & Dohme LLC	Chronic Lymphocytic Leukaemia	PHASE2	0

Registry history

First registered study	October 2022 — NCT05579132 (MSD R&D (China) Co., Ltd.)
Registered studies matching this name	7 all-time · 6 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Other Chronic Lymphocytic Leukaemia drugs

SNS-062

← Eichor home · All tracked trials · Chronic Lymphocytic Leukaemia studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →